Prof Miles Prince AM provides an update on COVID 19

Bringing you your weekly update on the impact of COVID 19 on blood cancer patients and carers. The key take home messages are: Keep up your social distancing it is hard but it is working We still have a lot to learn about this virus in terms of immunity and who is at greatest risk … Continued

Free online Meditation and Movement

A truly wonderful offer has been made available to Snowdome supporters by Ash Packman at The Fifth Direction.  Ash is offering his online meditation and movement classes free of charge to anyone following the Snowdome Foundation.  This offer comes at a time when we are all feeling anxious, uneasy and isolated.  Meditation has the ability … Continued

Snowdome Foundation 2019 Annual Review

We are proud to share with you the Snowdome Foundation 2019 Annual Review. The review celebrates 10 years of ‘making hope real’ for Australian blood cancer patients. We hope you are just as proud of our achievements as we are because we truly believe that every donation, every pro bono offer of support and every … Continued

Cancer free after genomic testing

18 months ago Snowdome spoke with Amanda Lindell while she was in the middle of treatment for her chronic lymphocytic leukaemia (CLL). CLL generally affects people 20 years older than Amanda and is usually a very slow cancer, smouldering away in the background. However, Amanda was young and her CLL was progressing rapidly. Her haematologist … Continued

Finding a novel way to kill all myeloma cells.

Myeloma is a cancer of the plasma cells. Your plasma cells are responsible for your immunity, they secrete large quantities of antibodies to fight off infection. Finding an effective treatment for myeloma has unfortunately baffled researchers for decades. Prof Stephen Nutt and his colleagues at the Walter Eliza Hall Institute are taking a different approach … Continued

CAR T-cell therapy funding granted for Lymphoma

The Medical Services Advisory Committee (MSAC) has given a positive recommendation to Kymriah a CAR T-cell therapy to treat refractory or relapsed diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) including transformed, and primary mediastinal B-cell lymphoma (PMBCL).  The treatment would cost an individual up to $500,000 but will now be funded by the government. In … Continued